ID   NZG-1003
AC   CVCL_D7DQ
SY   NZG1003
RX   PubMed=32320427;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
RX   PubMed=32320427; DOI=10.1371/journal.pone.0231470; PMCID=PMC7176076;
RA   Fabre M.-S., Stanton N.M., Slatter T.L., Lee S., Senanayake D.,
RA   Gordon R.M.A., Castro L.M., Rowe M.R., Taha A., Royds J.A., Hung N.,
RA   Melnick A.M., McConnell M.J.;
RT   "The oncogene BCL6 is up-regulated in glioblastoma in response to DNA
RT   damage, and drives survival after therapy.";
RL   PLoS ONE 15:e0231470.1-e0231470.24(2020).
//